Table 3.
Controls (n = 18) | PS (n = 16) | iPAH (n = 18) | P‐value iPAH to PS | |
---|---|---|---|---|
RVFW peak (msec)a | 473 ± 59 | 562 ± 76** | 638 ± 76* | 0.031 |
LVPW peak (msec)a | 478 ± 48 | 538 ± 70# | 564 ± 80* | 0.547 |
Septal peak (msec)a | 442 ± 74 | 435 ± 70 | 478 ± 51 | 0.212 |
Septal‐D peak*, a | – | – | 613 ± 63 | – |
TOC (msec)a | 58 ± 31 | 91 ± 24** | 122 ± 36* | 0.003 |
PV opening (msec)b | 66 ± 12 | 81 ± 29 | 178 ± 76* | 0.001 |
PV closure (msec)b | 445 ± 52 | 514 ± 68* | 500 ± 73 | 0.079 |
ET RVOT (msec) | 374 ± 48 | 451 ± 60* | 364 ± 62 | 0.001 |
AV opening (msec)b | 83 ± 14 | 95 ± 15# | 130 ± 40* | 0.15 |
AV closure (msec)b | 433 ± 52 | 461 ± 57 | 490 ± 63# | 0.923 |
ET LVOT (msec) | 354 ± 44 | 362 ± 46 | 375 ± 45 | 0.538 |
MV opening (msec)c | 492 ± 52 | 537 ± 69# | 592 ± 90* | 0.520 |
TV opening (msec)c | 478 ± 55 | 541 ± 88# | 667 ± 98* | 0.04 |
IVRT LV (msec) | 63 ± 14 | 73 ± 16 | 103 ± 24* | 0.015 |
TDI IVCT RV (msec) | 70 [61–102] | 61 [48–85] | 90 [58–139]** | <0.001 |
TDI IVRT RV (ms) | 28 [0–43] | 33 [24–123] | 95 [61–165] * | <0.001 |
MV inflow (msec)c | 545 ± 49 | 531 ± 63 | 482 ± 82# | 0.827 |
TV inflow (msec)c | 557 ± 62 | 484 ± 87 | 399 ± 88* | 0.251 |
Timing measurements normalized for the RR interval, patients compared with controls using ANOVA with Dunnet's; # P < 0.05, *P < 0.01, **P < 0.001. Pulmonary stenosis (PS) are compared to idiopathic pulmonary arterial hypertension (iPAH) patients using ANCOVA using right ventricular systolic pressure as a covariate.
RVFW, Right ventricular free wall; LVPW, Left ventricular posterior wall; D, diastolic peak; TOC, time to onset of contraction; PV, pulmonary valve; AV, aortic valve; MV, mitral valve; TV, tricuspid valve; IVRT, isovolumetric relaxation time.
RVFW peak missing in 4 controls, 2 PS and 1 iPAH patients, these were excluded for all M‐mode measurements.
VA valve opening missing in 6 iPAH and 1 PS patient.
AV opening was missing in 5 iPAH and 1 PS patient.